Ace Therapeutics scientists’ deep experience across a broad range of IBD will guide you to the most appropriate assays based on your therapeutic area of focus or target class of interest. Our teams stay at the forefront of therapeutic knowledge so they can generate the most actionable data for your research. Our cross-disciplinary expertise enables us to work efficiently with fast turnaround times—without compromising quality.
Our team of experienced experts can perform colonoscopy on various species including mice and rats. Using state-of-the-art equipment and techniques, we help clients visualize the inside of the colon, perform biopsies for further analysis, and monitor disease progression over time.
Ace Therapeutics has well-established imaging technology platforms to address clients' imaging needs in animal models of IBD. Our advanced imaging techniques not only allow direct visualization of intestinal inflammation, but also enable molecular imaging and targeting of specific alterations of the inflamed murine mucosa.
Ace Therapeutics provides integrated research solutions for the study of the gut microbiota in IBD, employing advanced metabolomics and high-throughput sequencing technologies. We aim to provide key insights into the pathogenesis of IBD and data to support the development of microbiome-based diagnostics and therapeutics for IBD.
Our team of experts provides in-depth characterization of intestinal epithelial barrier genes in IBD animals, incorporating genetic and transcriptomic approaches to help clients better understand the genes and intestinal epithelial barrier components associated with the disease.